Apellis Pharma director Dunlop sells $713,561 in shares
NeutralFinancial Markets

Apellis Pharma's director, Dunlop, has sold shares worth $713,561. This transaction is noteworthy as it reflects the director's financial decisions and could influence investor perceptions of the company. Such sales can sometimes raise questions about the company's future prospects, but they are also common in corporate governance.
— Curated by the World Pulse Now AI Editorial System